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ABSTRACT 28	
 29	
Cyathostomins are ubiquitous pathogenic nematodes of horses. Once ingested, these 30	
parasites can spend a substantial part of their life cycle as encysted larvae in the large 31	
intestinal wall.  The larvae can comprise up to 90% of the total cyathostomin burden, with 32	
up to several million worms reported in some individuals.  These developmental stages are 33	
pivotal in cyathostomin pathogenicity as they can emerge from the intestinal wall in large 34	
numbers to cause a life-threatening colitis.  Direct methods for the detection of encysted 35	
larval burdens in live horses do not exist.  Previously, two native antigen complexes were 36	
identified as promising markers for infection.  A component of these, cyathostomin gut 37	
associated larval antigen-1 (Cy-GALA-1), was subsequently identified following the 38	
immunoscreening of a complementary (c)DNA library using sera from infected ponies.  39	
Serum IgG(T) responses to recombinant Cy-GALA-1 were shown to inform on encysted 40	
larval infection.  Sequence analysis of PCR products amplified from DNA from individual 41	
identified worms indicated that Cy-GALA-1 was derived from the common species, 42	
Cyathostomum pateratum.  As cyathostomin infections always comprise multiple species, 43	
a diagnostic test must account for this.  Here, segments of the orthologous Cy-gala gene 44	
were isolated from four additional common species, Cyathostomum catinatum, 45	
Cylicocyclus ashworthi, Cylicostephanus goldi and Cylicostephanus longibursatus and the 46	
associated proteins expressed in recombinant form.  The cyathostomin specificity and 47	
immunogenicity of each recombinant protein was confirmed.  Each GALA protein was 48	
assessed by ELISA for its predictive ability for informing on the presence of encysted 49	
larval infection and the level of burden.   50	
 51	
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1. Introduction 55	
 56	
Parasitic nematodes of the group Cyathostominae are a potential cause of serious 57	
disease in equids of all types and ages.  These parasites have a high prevalence and most 58	
horses that graze encounter these infections (Matthews, 2008).  Cyathostomins exist as a 59	
group of around 50 species (Lichtenfels et al., 2008); however, most infections comprise 60	
5-10 common species, with low numbers of rarer species present (Chapman et al., 2002a).  61	
The species compositions are similar across regions, with the same group of species 62	
appearing as the most prevalent globally (Ogbourne, 1976; Reinemeyer et al., 1984; 63	
Mfitilodze and Hutchinson, 1990; Bucknell et al., 1995; Gawor, 1995; Lichtenfels et al., 64	
2001; Collobert-Laugier et al., 2002).  For all species, the life cycle involves a period of 65	
larval encystment in the wall of the caecum or large colon and these larvae can persist for 66	
prolonged periods of up to 2 years (Gibson, 1953; Smith, 1976; Murphy and Love, 1997).  67	
In some horses, the encysted larvae can constitute up to 90% of the total burden, with 68	
some individuals harbouring millions of worms (Dowdall et al., 2002).  Encysted larvae 69	
are important in the pathogenesis of cyathostomin infections, because these 70	
developmental stages can re-emerge from the intestinal wall in great numbers to cause 71	
larval cyathostominosis, a colitis syndrome that can be fatal in up to 50% of cases (Giles 72	
et al., 1985; Love et al., 1992).  Larval cyathostominosis is most commonly observed in 73	
horses of 2 to 5 years of age (Reid et al., 1995); however, animals can have a lifelong 74	
susceptibility to infection and disease has been observed in horses of all ages (Mair, 75	
1993).  The potential clinical effects of cyathostomins are confounded by the high levels 76	
of anthelmintic resistance in these nematodes, with resistance to benzimidazole and 77	
pyrantel compounds almost ubiquitous in some regions (Kaplan, 2002; Matthews 2014).  78	
The macrocyclic lactones are by far the most commonly used anthelmintics in horses and 79	
reduced efficacy against cyathostomins has been reported for ivermectin in Brazil 80	
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(Canever et al., 2013), with several studies reporting a shortened strongyle egg 81	
reappearance period following ivermectin (Geurden et al 2014; Relf et al., 2014) and 82	
moxidectin (Rossano et al., 2010; Relf et al., 2014) treatment.  A shortened helminth egg 83	
reappearance period is generally regarded as an early indicator of resistance (Sangster, 84	
1999), highlighting the threat of cyathostomin resistance to all available classes of broad 85	
spectrum anthelmintic.   86	
Anthelmintic targeting of cyathostomin encysted larvae is now common practice in 87	
equine helminth control programmes (Stratford et al., 2014).  Moxidectin and 88	
fenbendazole (administered over 5 consecutive days) are registered for this purpose 89	
(Matthews, 2008); however, because of high levels of resistance to fenbendazole, 90	
moxidectin is the only remaining compound effective against encysted larval stages, so its 91	
efficacy needs to be preserved.  To address this, a reduction in treatment frequency is 92	
recommended (Matthews, 2014).  This can be achieved by improving grazing practices to 93	
reduce cyathostomin transmission via the environment, combined with specific targeting 94	
of treatments based on strongyle egg shedding (Nielsen et al., 2006; Nielsen et al., 2014; 95	
Lester and Matthews, 2014).  Such protocols do not address the presence of encysted 96	
larvae within individuals.  Indeed, horses with sizeable encysted larval burdens often have 97	
no or low egg shedding (Dowdall et al., 2002).  Because of these issues, a test that informs 98	
on the presence or burden of encysted larvae would facilitate anthelmintic targeting of 99	
these stages and would also assist in the definitive diagnosis of larval cyathostominosis, a 100	
challenge in practice due to the non-specific nature of the associated clinical signs (Giles 101	
et al., 1985).  Previously, these authors identified two native antigen complexes that 102	
showed promise as diagnostic markers of encysted larval infection (Dowdall et al., 2002, 103	
2003, 2004).  The antigen preparations are, however, labour intensive to prepare and rely 104	
on a continual source of equine intestinal tissue.  For these reasons, steps were taken to 105	
identify genes that encode protein components of these complexes to develop a 106	
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recombinant protein-based test.  One component, cyathostomin gut associated larval 107	
antigen-1 (Cy-GALA-1) protein, was identified by immunoscreening a cyathostomin 108	
larval complementary (c)DNA library using sera from infected ponies (McWilliam et al., 109	
2010).  Sequence analysis of PCR products amplified from DNA from individual 110	
identified worms indicated that Cy-GALA-1 was derived from the common species, 111	
Cyathostomum pateratum, so Cy-GALA-1 was re-designated Cy-GALA-pat (McWilliam 112	
et al., 2010).   Recombinant Cy-GALA-pat was demonstrated to be the target of serum 113	
IgG(T) responses in infected, but not in uninfected horses, and exhibited no reactivity to 114	
serum from horses specifically infected with non-cyathostomin helminth species.  In 115	
experimentally- and naturally-infected horses, antigen-specific IgG(T) levels to the 116	
protein were significantly higher than those in cyathostomin-negative animals, with 117	
antigen-specific IgG(T) levels shown to have a significant positive correlation with 118	
encysted larval burden (McWilliam et al., 2010).  As horses invariably harbour a range of 119	
cyathostomin species, a diagnostic test may need to take account of the complex nature of 120	
these infections.  Here, recombinant GALA proteins were generated from four additional 121	
common cyathostomin species and the specificity and immunogenicity of each examined.  122	
These proteins were then assessed by ELISA for their ability to predict cyathostomin 123	
encysted larval infection and the level of burden. 124	
 125	
2. Materials and methods 126	
2.1. Parasite material 127	
Individual adult cyathostomins were removed from the large intestinal luminal contents 128	
of naturally-infected horses at post mortem (Dowdall et al., 2002).  The worms were 129	
identified to species by morphological means based on the key of Lichtenfels et al. (2008).  130	
Cyathostomin encysted larvae were recovered by pepsin-HCl digestion or by manual 131	
removal from the mucosa and submucosa as described previously (Dowdall et al., 2002).  132	
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 133	
2.2. Sub-cloning and recombinant protein expression of Cy-Gala proteins from an 134	
additional four cyathostomin species 135	
Like Cy-GALA-pat, two of the additional proteins were derived from clones selected 136	
by immunoscreening (McWilliam et al. 2010).  Similar to the strategy used to ascribe a 137	
species identity to Cy-gala-pat, nucleotide sequences in these two additional clones were 138	
compared to gala sequences obtained by PCR amplification from numerous individual 139	
identified worms of various species.  Based on this analysis, the clones were ascribed to 140	
the common species, Cylicocyclus ashworthi (sequence named as Cy-gala-ash) and 141	
Cyathostomum catinatum (sequence named as Cy-gala-cat).  For recombinant protein 142	
expression, Cy-gala-ash and Cy-gala-cat sequences were used to design primers to 143	
facilitate PCR amplification of Cy-gala encoding sequence (minus the signal peptide 144	
sequence) from phage plaque eluates from respective clones selected by immunoscreening 145	
(McWilliam et al. 2010).    Sequences encoding restriction enzyme sites were incorporated 146	
into each primer to facilitate unidirectional cloning.  The primer sequences were: Cy-gala-147	
ash (SacI, NotI sites underlined) sense 5’-148	
ATTCGAGCTCCCATGAAGAACTTCGTCGTCAC-3’, antisense 5’-149	
AGCTTGCGGCCGCATATCTTCTATCCGTGTTGAG-3’; Cy-gala-cat (NcoI, NotI sites 150	
underlined) sense 5’-ATGGCCATGGATGAGGATCGTGAAGAACATCGC-3’, 151	
antisense 5’- AGCTTGCGGCCGCATCTCTTTCATCTGTGTTGAGTCC-3’.  The PCR 152	
conditions were as follows: 0.5 µM primers, 0.2 mM dNTPs and 1.5 mM MgCl2, with 153	
cycling conditions, 94°C for 2 min, 30 cycles at 94°C for 15 sec, with an annealing 154	
temperature of 54°C (Cy-gala-ash) or 53°C (Cy-gala-cat) for 30 sec, and 72°C for 60 sec, 155	
with a final cycle of 72°C for 7 min.  Amplifications were performed using Platinum Taq 156	
(Invitrogen) in combination with 2 µl of each phage plaque eluate in a reaction volume of 157	
50 µl.  For size determination, PCR products were analysed on 1.1% w/v agarose TAE 158	
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gels using a TrackIt 100bp DNA Ladder (Invitrogen) and stained with 1 x GelRed 159	
(Biotium).  Next, the expression plasmid (pET-22b(+), Novagen) and each PCR product 160	
were digested with the appropriate restriction enzymes and ligation of the PCR amplicons 161	
performed using T4 ligase (Promega).  The derived plasmids were transformed into 162	
Escherichia coli JM109 competent cells (Promega) and selected on ampicillin-LB agar.  163	
For each species, one colony containing plasmid with an insert of the correct size was 164	
subjected to plasmid purification (Wizard Plus SV Miniprep kit, Promega) and the insert 165	
sequenced in full to confirm identity.  On confirmation of sequence identity, plasmids were 166	
transformed into E. coli BL21-CodonPlus(DE3)-RIL competent cells (Stratagene) for 167	
expression of recombinant (r) Cy-GALA-ash and Cy-GALA-cat.  Recombinant protein 168	
expression was induced as described in McWilliam et al. (2010).  Similar to rCy-GALA-169	
pat (McWilliam et al., 2010), rCy-GALA-cat was soluble and present in the bacterial 170	
lysate supernatant.  This protein was purified directly on a HisTrapHP column (GE 171	
Healthcare), eluted in increasing concentrations of imidazole, then dialysed with 20 mM 172	
sodium phosphate, 0.5M NaCl (pH 7.4), and stored at -20 °C. The rCy-GALA-ash protein 173	
was insoluble, so purification and dialysis were carried out as above, with the exception 174	
that 8 M urea was added to all buffers.  For isolation of gala sequences from Cylicocyclus 175	
goldi and Cylicostephanus longibursatus, degenerate primers (sense 5’-176	
ACAGTCGTTAGTGCCGTAGTCCT-3’, antisense 5’-177	
TTGAGTCCAAACATTCTTCCATT-3’) were designed using all of the gala sequences 178	
described above and used to PCR-amplify a portion of the gala gene from single, 179	
identified adult C. goldi and C. longibursatus using cDNA synthesised as described in 180	
Lake et al. (2009).  The PCR products were cloned into pGEM®-T Easy vector (Promega), 181	
plasmid preparations made and the inserts sequenced in both directions.  Next, to generate 182	
PCR products for sub-cloning for protein expression, species-specific primers were 183	
designed using the C. longibursatus and C. goldi sequences obtained from individual 184	
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identified worms.  For each, primer sequences (SacI and NotI restriction sites underlined) 185	
were: Cy-gala-gol sense 5’-ATTCGAGCTCCCAAGGTGTCATGGCCCTATTTG-3’, 186	
antisense 5’-ATTAGCGGCCGCCAGGTATCTTCTATCCGTGTTCAG-3’, and for Cy-187	
gala-lon sense 5’-ATTCGAGCTCCCAAGGTGTCATGGACCTTTTTGG-3’, antisense 188	
5’-ATTAGCGGCCGCATATCTTCTATCCGTGTTGATTCCG-3’.  PCR conditions were 189	
as above, except that 0.25 µM primers and 0.4 µl of Platinum Taq were used in reaction 190	
volumes of 100 µl, and 30 amplification cycles performed with an annealing temperature 191	
of 58oC.  The PCR products and vector were digested with SacI (Promega) and NotI 192	
(Promega) and ligated into pET-22b(+) vector.  Plasmids were transformed into E. coli 193	
JM109 Competent Cells (Promega) and selected on ampicillin-LB agar.  Colonies were 194	
examined by PCR for the presence of an insert of the correct estimated size using vector-195	
specific primers and plasmid preparations made from two colonies, which were sequenced 196	
using the same primers.  Clones of the correct sequence were transformed into BL21-197	
CodonPlus(DE3)-RIL cells as above.  Recombinant Cy-GALA-lon and Cy-GALA-gol 198	
were insoluble so were prepared and stored in the presence of 8M urea as above.   199	
Nucleotide and amino acid sequence alignments were performed using ClustalW2 (Larkin 200	
et al., 2007) and the levels of sequence identity examined using MegAlign 10.0.1 201	
(DNASTAR) based on the ClustalW2 alignments.  Signal peptides were identified using 202	
SignalP 4.0 (Petersen et al, 2011).  The sequences were translated and their molecular 203	
mass estimated using the Sequence Manipulation Suite 204	
(http://www.bioinformatics.org/sms2/protein_mw.html).  205	
 206	
2.3. Immunogenicity and specificity of recombinant GALA proteins tested by 207	
immunoblotting 208	
To assess immunogenicity and potential cross reactivity of each recombinant GALA 209	
protein, binding of IgG(T) in sera from horses infected only with cyathostomins or with 210	
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single-species experimental infections of heterologous helminths was investigated.  For 211	
immunoblotting, IgG(T) reactivity to each protein was assessed in sera pooled from three 212	
experimental cyathostomin-infected (CI) ponies at 12-16 weeks post infection (Murphy 213	
and Love, 1997).  These time points were selected on the basis of high serum IgG(T) 214	
reactivity to native encysted larval antigen complexes identified in Dowdall et al. (2002).  215	
Pools of negative control sera were prepared from samples obtained from three control 216	
ponies raised and maintained under helminth-free (HF) conditions (Murphy and Love, 217	
1997).  Cross reactivity of the GALA proteins was tested using sera from horses mono-218	
specifically infected with either Strongylus edentatus or Strongylus vulgaris (Klei et al., 219	
1982) and either Parascaris equorum or Strongylus westeri (Dowdall et al., 2003).  Serum 220	
IgG(T) reactivity was also assessed in a serum pool from seven naturally-infected horses 221	
from the UK (UK+): this material was collected at an equine abattoir and each horse 222	
included had a total mucosal burden (TMB) of more than 100,000 cyathostomin encysted 223	
larvae (Dowdall et al., 2002).  Further, serum IgG(T) reactivity in a pool of sera derived 224	
from 11 clinical cases of larval cyathostominosis (UK+Clin) was assessed.  These horses 225	
were classified as cases based on their presenting signs and the detection of large numbers 226	
of cyathostomin larvae in their faeces (Hodgkinson et al., 2003).  For immunoblotting, 0.1 227	
µg of each protein was loaded, per lane, onto a 15-well, 12% NuPAGE gel with SeeBlue 228	
Plus2 protein standards used for size estimations (Invitrogen).  An additional lane was 229	
loaded with 0.1 µg protein.  After electrophoresis, this lane was removed and stained with 230	
Coomassie blue for comparison with the immunoblots.  Blocking, primary, secondary and 231	
tertiary antibody steps and blot development were as described in McWilliam et al. (2010).  232	
To examine if the recombinant proteins were reactive with sera to the native antigen 233	
complex (Dowdall et al., 2003) and to sera raised against Cy-GALA-pat (McWilliam et al., 234	
2010), IgG reactivity in rabbit sera to both was assessed as described in McWilliam et al. 235	
(2010). 236	
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 237	
2.4. Immunoreactivity of the individual recombinant GALA proteins tested by ELISA 238	
Once the immunogenicity and specificity of each of the four new GALA proteins was 239	
confirmed by immunoblotting, the ELISA was used to evaluate serum IgG(T) levels to 240	
each.  Serum IgG(T) responses to rCy-GALA-pat were compared in these studies also.  241	
Antigen-specific IgG(T) levels were assessed in cohorts of horses from the UK (UK+) and 242	
from the US (US+) for which the cyathostomin burden was known and in a cohort of 243	
larval cyathostominosis cases.  The UK+ group comprised 25 horses sampled at a UK 244	
abattoir (Dowdall et al., 2004) and three experimentally infected ponies (Murphy and 245	
Love, 1997).  Cyathostomin burdens in these horses were quantified with the TMB and 246	
total worm burden (TWB) calculated as described previously (Dowdall et al., 2004).  247	
Antigen-specific IgG(T) levels were also measured in 11 larval cyathostominosis cases 248	
from the UK (UK+Clin; Hodgkinson et al., 2003).  Serum IgG(T) levels in these cohorts 249	
were compared with those in six UK HF ponies (UK-, see Section 2.3 and Murphy and 250	
Love, 1997).  Several groups of cyathostomin-infected horses from the US (US+) were 251	
assessed for serum IgG(T) levels to each antigen.  One group comprised 10 naturally-252	
infected horses from Louisiana (Monahan et al., 1996).  Another comprised 38 ponies 253	
subjected to various cyathostomin experimental infection/treatment regimens (Monahan et 254	
al., 1997; Monahan et al., 1998; Chapman et al., 2002b).  Serum IgG(T) levels in these 255	
cohorts were compared with those in cyathostomin-free ponies that were infected with S. 256	
vulgarus, P. equorum and S. westeri (US-, n=3).  For studying serum IgG(T) response 257	
dynamics in experimentally-infected ponies, antigen-specific IgG(T) levels were measured 258	
up to 16 weeks post infection in samples taken weekly from 2 weeks before infection, with 259	
the exception of week 9 and 11 post infection (Murphy and Love, 1997).  The ELISA 260	
plates (96-well flat bottomed Microlon High binding plates, Greiner Bio-One) were coated 261	
with the inidivual rGALA antigens at 2 µg/ml.  Each well was coated with 100 µl of 262	
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antigen in coating buffer (0.1 M carbonate coating buffer, pH 9.6) overnight at 4 oC.  Plates 263	
were then washed six times with 0.05% Tween-20 in PBS (PBS-T), then blocked using 264	
200 µl block buffer (2% soya powder (InfasoyTM’ Cow and Gate Ltd), w/v in PBS), per 265	
well for 1 h at 37oC.  All serum dilutions were made in block buffer.  The plates were 266	
washed three times (as above) and 100 µl sera (diluted 1:800) added to each well and 267	
incubated for 2 h at 37oC.  Each serum sample was tested in triplicate.  Plates were washed 268	
six times, incubated for 1 h with (100 µl per well) goat anti-equine IgG(T) whole molecule 269	
(Serotec), diluted 1:400 in block buffer.  The plates were washed six times, then 100 µl 270	
rabbit anti-goat Ig:HRP conjugate (Sigma), diluted 1:500 in block buffer, added to each 271	
well and incubated for 1 h at 37oC.  The reactions were developed by adding 100 µl o-272	
Phenylenediamine dihydrochloride solution prepared from SIGMAFAST OPD tablets 273	
(Sigma) to each well.  After 15 min at room temperature, 50 µl 2.5 M H2SO4 were added 274	
to stop the reactions and the absorbance in each well read at 490 nm.  On all plates, 275	
aliquots from the same pool of CI sera were tested in triplicate as a control for inter-plate 276	
variation.  The results derived from all samples were then expressed as the percentage OD 277	
of the CI sample mean for each plate.  Minitab 17 Statistical Software for Windows was 278	
used to analyse the data.  For the different infected groups (UK+, UKClin+, US+), the 279	
group medians of the percentage positivity were compared to those of the cyathostomin-280	
free horses (UK- and US-) by the Mann-Whitney test. A p value <0.05 was taken to 281	
indicate statistical significance. 282	
 283	
2.5. Receiver Operator Characteristic (ROC) Curve analysis 284	
Receiver operator characteristic (ROC) curve analysis was performed to indicate the 285	
accuracy of each rGALA protein ELISA result relating to cyathostomin infection (postive 286	
or negative) and to cyathostomin TMB and TWB.  As an estimate of test accuracy, the 287	
area under the curve (AUC) may be interpreted such that; AUC = 0.9-1.0 demonstrates an 288	
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excellent level of discrimination between positive and negative results; AUC = 0.8-0.9 289	
good discrimination; AUC = 0.7-0.8 fair discrimination; AUC = 0.6-0.7 poor 290	
discrimination and AUC = 0.5-0.6 no discrimination (Swets, 1988).  The ELISA data were 291	
subjected to ROC analysis using Prism 6 (Graphpad Software Inc, USA).  292	
 293	
3. Results 294	
3.1. Analysis of GALA sequences from the four additional cyathostomin species  295	
Alignment (Figure 1) of the derived GALA protein sequences demonstrated that, like 296	
Cy-GALA-pat, all sequences from the additional four species contained an N-terminal 297	
histidine-rich motif and a highly-conserved domain (Marchler-Bauer et al., 2007), the 298	
function of which is unknown, and which is termed as  Domain of Unknown Function 148 299	
in the two most closely related sequences from Caenorhabditis elegans.  Comparative 300	
analysis (Table 1) indicated that the sequences were between 83.3% (Cy-GALA-ash) and 301	
92.9% (Cy-GALA-cat) identical to Cy-GALA-pat at the amino acid level.  The level of 302	
intra-specific identity in the derived amino acid sequences was higher than 90% for all five 303	
species examined.  304	
 305	
3.2. Immunoreactivity and cyathostomin specificity of the rGALA proteins 306	
Coomassie staining of the four new rGALA proteins (Figure 2A) demonstrated that the 307	
approximate size observed for each corresponded to the calculated molecular mass.  The 308	
immunoblot experiments demonstrated that IgG(T) in sera from HF ponies did not bind to 309	
any of the four rGALA proteins, whilst IgG(T) in sera from ponies experimentally infected 310	
with cyathostomins (CI sera) bound to all four proteins (Figure 2B).  In terms of cross 311	
reactivity to other helminth species, there was no, or negligible, IgG(T) binding to each of 312	
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the four rGALA proteins observed in sera from horses infected mono-specifically with P. 313	
equorum, S. edentatus, S. vulgaris and S. westeri (Figure 2B).  To further examine the 314	
immunogenicity of the proteins in naturally-infected horses, immunoblots were performed 315	
using sera pooled from horses that presented at an abattoir and which had high encysted 316	
larval burdens.  Here, strong reactivity of IgG(T) to all four rGALA proteins was observed 317	
(Figure 3A).  Likewise, IgG(T) in sera pooled from samples from larval cyathostominosis 318	
cases demonstrated strong reactivity to all proteins (Figure 3B).  The rGALA proteins also 319	
bound IgG in sera from a rabbit immunised with the native 20 kDa complex originally 320	
identified in encysted larvae (Dowdall et al. 2003, Figure 3C).  Similarly, IgG in sera from 321	
a rabbit immunised with rCy-GALA-pat bound each of the four new GALA proteins 322	
(Figure 3D).  No binding was observed in pre-immunisation sera from either rabbit. 323	
 324	
3.3. ELISA and ROC curve analysis of serum IgG(T) responses to rGALA proteins in 325	
cyathostomin-infected horses 326	
A time course study was performed to analyse serum IgG(T) responses to each protein 327	
in experimentally-infected ponies across a primary trickle infection (Figure 4).  The 328	
IgG(T) responses in the infected ponies (Ponies 101, 104, 105) were analysed from before 329	
infection until 16 weeks after initial challenge. The levels of antibody in these individuals 330	
were compared to those in ponies that remained uninfected throughout the protocol 331	
(Ponies 102, 103, 106). Similar to previous observations with rGALA-pat (McWiliam et 332	
al., 2010), increases in antigen-specific IgG(T) were observed against all recombinant 333	
proteins after infection; however, the dynamics of the IgG(T) repsonse to each protein 334	
varied amongst the individuals.  Serum IgG(T) responses to rGALA-ash, lon and gol 335	
proteins increased more rapidly in Pony 104 than in the other two infected ponies.  This 336	
was not the case with respect to IgG(T) responses to the rGALA-cat protein, against which 337	
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IgG(T) levels increased more slowly than to the other proteins.   In Pony 104, IgG(T) 338	
levels to rGALA-ash, gol and lon plateaued after 7 weeks post-infection and remained 339	
high until the end of the time course.  Antigen-specific serum IgG(T) levels in Ponies 101 340	
and 105 increased at a slower rate, but generally reached similar levels to  those measured 341	
in Pony 104 by the end of the time course, with the exception of Pony 101’s IgG(T) 342	
response to rGALA-cat.  Increases in antigen-specific IgG(T) levels were not observed in 343	
any of the HF ponies across the time course. 344	
Next, levels of serum IgG(T) to all four new rGALA proteins and rGALA-pat were 345	
analysed in equids for which cyathostomin burden data were available allowing 346	
comparison of parasitological parameters with specific antibody levels in matched end-347	
point blood samples.  Also analysed were rGALA-specific serum IgG(T) responses in 348	
horses that presented with larval cyathostominosis.  First, serum IgG(T) levels were 349	
compared in cyathostomin-infected groups (UK+, US+, UKClin+) with those in 350	
cyathostomin-negative groups (UK-, US-) from the UK and the US.  For the UK+ and 351	
UKClin+ cohorts, for all five GALA proteins, specific IgG(T) levels were significantly 352	
higher than in the cyathostomin-negative horses (Table 2).  Likewise, for the US 353	
population, the levels of IgG(T) to each recombinant protein were significantly higher in 354	
the US+ group than in the US- cyathostomin-free group.  The ELISA data from horses for 355	
which cyathostomin burdens were available were then subjected to ROC curve analysis.  356	
For all five proteins, serum rGALA-specific IgG(T) levels in equids which were known to 357	
be truly cyathostomin negative (i.e. the UK- and US- groups) were compared to rGALA-358	
specific IgG(T) levels measured in cyathostomin-infected horses from the UK or the US 359	
(Table 3).  Here, high ROC curve AUC values (i.e. >0.9) were obtained for all 360	
recombinant proteins (AUC values: ‘ash’ and ‘lon’ > ‘pat’ > ‘cat’ > ‘gol’).  The highest 361	
sum of percentage sensitivity and specificity values generated in this ROC analysis were 362	
then used to calculate cut-off percentage positivity thesholds for each rGALA protein 363	
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(Table 3).  Based on these values, the specificity ranged from  82.43% (ash) to 95.95% 364	
(cat) and sensitivity from 77.78% (cat, gol) to 100% (ash and pat).  When the data were 365	
stratified at different cyathostomin TMB thresholds taking into account that some horses 366	
negative for TMB were positive for cyathostmin lumenal parasites (Table 4), the AUC 367	
values and the sensitivity and specificity values calculated were lower. Next, TWB 368	
thresholds were examined to assess if the outputs were likely to be confounded by the half-369	
life of rGALA-specific serum IgG(T) responses; for example, in equids where there had 370	
been a recent emergence of high numbers of previously-encysted larvae or in equids that 371	
had been administered recently with an effective larvicidal treatment. Indeed, when the 372	
cohort was stratified on the basis of cyathostomin TWB, for all rGALA proteins, the AUC 373	
and sensitivity and specificity values were higher than when the group was stratified on the 374	
basis of TMB alone (Table 4).  For the 0 TWB threshold, the AUC values for IgGT) 375	
responses to all all five rGALA proteins was high (i.e. > 0.9).  Finally, the cohort was 376	
statfied on the basis of a threshold of 5,000 mucosal larvae or TWB.  At a cut-off of a 377	
TMB of 5,000 larvae, the AUC values ranged from 0.69 (rGALA-ash) to 0.77 (rGALA-378	
cat), so giving ‘good’ discrimination.  At a cut-off of 5,000 total worms, the rGALA-cat 379	
and rGALA-lon (AUC values for both = 0.82) gave the highest values, with the AUC 380	
values for the other rGALA protiens exceeding 0.7.  When the data were partitioned such 381	
that the threshold value was 10,000 TMB or TWB, most AUC values generated were <0.7 382	
(data not shown).    383	
 384	
 4. Discussion 385	
Cyathostomins have high pathogenic potential in equids due to their capacity to cause 386	
life-threatening colitis when encysted larvae emerge from the intestinal wall.  For this 387	
reason, the administration of anthelmintics that have activity against these developmental 388	
stages is regarded as an essential component of parasite control programmes (Nielsen 389	
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2012; Matthews 2014).  As there is no diagnostic test capable of detecting encysted larval 390	
stages, current recommendations are to apply whole-group larvicidal treatments at the 391	
appropriate time of year (Matthews, 2008; Nielsen et al., 2014).  As it is likely that most 392	
horses will not carry life-threatening levels of encysted larvae, the availability of a 393	
diagnostic test that can inform on the presence or burden of these stages would help in 394	
directing the strategic? application of larvicidal anthelmintic treatments.  395	
The development of a diagnostic test for cyathostomins is complicated by the complex 396	
nature of this group of nematodes.  There are 50 recognised cyathostomin species 397	
(Lichtenfels et al., 2008); however, whilst a range of species is found in individuals, the 398	
majority of the burden has been found consistently across studies and geographic regions 399	
to comprise 5-10 common species.  The species investigated here were selected on the 400	
basis that they were the most prevalent species identified across multiple studies.  In 401	
particular, C. longibursatus and C. catinatum are regularly recorded as the commonest 402	
species recovered from horses across different continents (Krecek et al., 1989 [South 403	
Africa]; Mfitilodze and Hutchinson 1990 [Tropical Australia]; Bucknell et al., 1995 404	
[Victoria, Australia]; Gawor, 1995 [Poland]; Lichtenfels et al., 2001 [UK], Chapman et al., 405	
2002a [USA]; Boxell et al., 2004 [Western Australia]; Kuzmina et al., 2005 [Ukraine]).  A 406	
representative protein for C. ashworthi was also selected here.  This species has been 407	
regarded as a synonym of Cylicocyclus nassatus; the two are similar morphologically but 408	
are now regarded as separate (Lichtenfels et al. 1997).  Earlier studies may have 409	
misidentified C. ashworthi (Chapman et al., 2002a), so this species may not have been 410	
represented appropriately in surveys based on nematode morphology.  Where C. ashworthi 411	
has been defined as distinct, it has been found at high prevalence (Lichtenfels et al., 2001; 412	
Kuzmina et al., 2005; Kornaś et al., 2009).  Likewise, both C. goldi and C. pateratum  are 413	
cyathostomin species detected in high abundance in surveys performed across different 414	
regions (Reinemeyer et al., 1984; Krecek et al., 1989;	Mfitilodze and Hutchinson, 1990; 415	
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Gawor, 1995; Boxell et al., 2004; Collobert-Laugier et al., 2002; Traversa et al., 2010).  As 416	
there does not appear to have been an obvious shift in the prevalence ranking of 417	
cyathostomin species over time (Chapman et al., 2002a), despite the advent and spread of 418	
anthelmintic resistance, it is with confidence that the inclusion of the species here 419	
represent common components of cyathostomin infections now as well as in the future.   420	
The level of intra-specific variation observed in the GALA sequence was low in all 421	
cyathostomin species studied (Table 1).  Further, the diversity observed in GALA 422	
sequence between these species was far lower than that seen when the GALA sequences 423	
were compared to orthologous sequences present in non-cyathostomin species (data not 424	
shown) indicating that the test is unlikely to be affected by cross-reactivity to non-425	
cyathostomin infections.  In agreement with this, the specificity of each rGALA protein 426	
was confirmed in immunoblotting experiments when each protein was probed with sera 427	
from horses mono-specifically infected with large strongyle species, P. equorum or S. 428	
westeri, and no reactivity was observed.  Further immunoblotting experiments 429	
demonstrated that all four rGALA proteins bound strongly to IgG(T) in serum pooled from 430	
cyathostomin-infected horses and in serum from clinical cases of larval cyathostominosis. 431	
These results were substantiated by the ELISA data which demonstrated significantly 432	
higher specific serum IgG(T) levels to each rGALA protein in the US and UK 433	
cyathostomin-infected groups compared to the respective cyathostomin-negative groups 434	
(Table 2).  The time course study supported these findings demonstrating robust anti-435	
rGALA serum IgG(T) responses in all infected ponies.  Similar to previous results 436	
obtained with the rCy-GALA-pat protein (McWilliam et al.,2010) and with the native 437	
antigens (Dowdall et al., 2002), specific IgG(T) increased to rGALA-ash, -gol and -lon in 438	
Pony 104 earlier than in the other two infected ponies.  The more severe clinical 439	
parameters in this pony indicated that it had developed the greatest burden of mucosal 440	
larvae during the infection period and when this animal was euthanized (at 20 weeks post-441	
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infection), it was found to have a very high (>700,000 cyathostomin larvae) burden, but a 442	
negative faecal egg count (Murphy and Love, 1997). The other two ponies had 443	
substantially lower cyathostomin burdens, but they were not necropsied until 60 and 62 444	
weeks post-infection so the burdens as enumerated cannot be directly compared with that 445	
of Pony 104.  The differences in the dynamics in IgG(T) response to the rGALA-cat 446	
protein may reflect the relative proportions in species present over the trickle infection 447	
period (Murphy and Love, 1997).  These observations indicate that the long term goal of 448	
this work should still be the development of a test incorporating several rGALA proteins 449	
derived from the commonest species, due to the potential risk of false negative results in 450	
some individuals in which a single species may be less abundant.  451	
The ROC AUC values obtained indicate that all five rGALA proteins provide excellent 452	
discriminatory information when comparing true cyathostomin-negative to true 453	
cyathostomin-postive individuals (Table 3).  The AUC values obtained were similar for all 454	
five rGALA proteins.  When horses were stratified on the basis of mucosal larval burden 455	
(Table 4), the derived ROC AUC values were lower than the values obtained when the true 456	
cyathostomin-negative group was compared to the cyathostomin-positive horses.  This is 457	
likely due to the fact that some horses in the TMB-negative group harboured lumenal 458	
stages of cyathostomins; such horses may have residual GALA-specific IgG(T) in their 459	
serum stimulated by a recent previous encysted larval infection.  This observation is 460	
unlikely to be due to cross-reactivity to antigens in lumenal worms, as it was demonstrated 461	
previously that GALA protein and gala transcript could not be detected in these stages of 462	
cyathostomins (McWilliam et al., 2010).  The serum half-life of equine IgG(T) has been 463	
measured as 21 days (Sheoran et al., 2000), so a limitation of this test is that, in horses that 464	
have had recent emergence of encysted larvae or have received a recent effective larvicidal 465	
treatment, rGALA-specific IgG(T) levels will still be elevated.  With this in mind, a future 466	
objective of ours will be to investigate the dynamics of circulating rGALA protein-specific 467	
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serum IgG(T) after anthelmintic treatments known to be effective against encysted larval 468	
stages.  This issue is not unique to the cyathostomin test and has been a topic of discussion 469	
with respect to the commercially-available diagnostic assay for Anoplocephala perfoliata 470	
in horses.  This latter diagnostic is also based on the binding of serum IgG(T) to  parasite 471	
proteins (Barrett et al., 2004; Abbott et al., 2008).  Despite these concerns, the A. 472	
perfoliata ELISA is still regarded as a useful diagnostic tool (Kjaer et al., 2007; Abbott 473	
and Barrett, 2008).   In both cases, the output of the test must always interpreted alongside 474	
the clinical and treatment history of the individual or population of animals being assessed.  475	
In terms of informing on cyathostomin burden, the rGALA tests performed well when 476	
used to discriminate horses at an encysted larval burden threshold of 5,000 worms (Table 477	
4).  At higher TMB thresholds (10,000 +), the ROC AUC values were lower (i.e. < 0.7) 478	
indicating that the tests could not discriminate horses above and below thresholds > 5,000 479	
larvae.  When the ROC curve analysis was repeated with horses segregated on the basis of 480	
threshold of TWB (i.e. mucosal and luminal nematode burdens, Table 4), the AUC values 481	
obtained were higher at the 5,000 TWB threshold compared to when the horses were 482	
grouped according to TMB.   Again, with this in mind, the test results will need to be 483	
interpretated in the context of the clinical or treatment history of individuals and also with 484	
respect to the time of year that the sample is anlysed.  In northern temperate climates, 485	
experimental studies (Reinemeyer et al., 1986) have shown that there is is a peak of 486	
cyathostomin larval luminal stages in spring (presumably derived from recently emerged 487	
encysted larvae acquired during the previous grazing season). These larvae develop to 488	
mature adults in late spring, which persist through summer and are added to by immature 489	
worms, which co-contribute to a second adult worm peak in late summer. In these studies, 490	
there was an apparent loss of adult worms and luminal larvae in autumn; hence, the 491	
rGALA ELISA is likely to provide most diagnostic value if used in these regions in 492	
autumn when it can be used to help inform the need for a larvicidal treatment.  A cocktail 493	
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of the five rGALA proteins, and combinations thereof, will now be assessed to see which 494	
should be combined to optimise the test to commercialisation. A balance will need to be 495	
struck between the resource required to generated each recombinant protein and the 496	
diagnostic value provided by the various rGALA combinations.  Once the final cocktail is 497	
selected, a large cohort of sera from naturally-infected horses will be tested to examine 498	
how many individuals fall above and below the selected cut-offs for 0 TMB and 5,000 499	
TMB.   500	
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Table 1. Details of the GALA sequences representing the recombinant proteins used in the 653	
ELISA. These are derived from the following cyathostomin species:  Cylicocyclus 654	
ashworthi (ash), Cyathostomum catinatum (cat), Cylicostephanus goldi (gol), 655	
Cylicostephanus longibursatus (lon) and Cyathostomum pateratum (pat).   656	
 657	
 658	
 659	
 660	
 661	
	662	
Accession numbers of the sequences representative of each clone used for expression for each 663	
species are as follows: Cy-gala-pat - FJ882059.1, Cy-gala-cat - JN596966, Cy-gala-gol - 664	
JN596967, Cy-gala-lon - JN596968, Cy-gala-ash - JN596964  665	
GALA 
protein 
name  
Number of worms sequenced 
per species (range of 
intraspecific variation in amino 
acid sequence as a percentage) 
Amino acid identity 
(%) to Cy-GALA-PAT 
sequence of each clone 
used for expression  
Predicted size of 
recombinant 
protein including 
His tag (kDa) 
ash 3 (95.5-97.2) 83.3 25.5 
cat 4 (92.9-97.3) 92.9 25.1 
gol 4 (90.8-100) 91.3 27.2 
lon 2 (97.1-100) 89.8 27.0 
pat 5 (94.7-97.6) 100  26.6 
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Table 2.  Comparison of serum IgG(T) levels in cyathostomin-infected versus non-666	
infected groups from the UK and the US.  Horses were naturally infected or were 667	
subjected to experimental infection. The UK+ population comprised 26 cyathostomin 668	
naturally-infected horses sampled at an abattoir. The UK- population comprised 6 669	
cyathostomin-negative ponies raised under helminth free conditions. The UKClin+ group 670	
comprised 11 equids that presented with larval cyathostominosis in practice. The US+ 671	
population (n=48) comprised natuarally- or experimentally-infected equids from the US 672	
and the US- population comprised three experimental equids from the US that were riased 673	
cyathostomin-free.  For the different infected groups (UK+, UKClin+, US+), the group 674	
medians of the percentage positivity were compared to that of the cyathostomin-free 675	
horses (UK- and US-) by the Mann-Whitney test.  A p value <0.05 was taken to indicate 676	
statistical significance. 677	
 678	
Groups compared rGALA protein P value 
UK+ (n=26) vs. UK- (n=6) ash 0.0007 
cat 0.0011 
gol 0.0018 
lon 0.0006 
pat 0.0006 
UKClin+ (n=11) vs. UK- (n=6) ash 0.0011 
cat 0.0077 
gol 0.0011 
lon 0.0022 
pat 0.0104 
US+ (n=48) vs. US- (n=3) ash 0.0172 
cat 0.0356 
gol 0.0392 
lon 0.0213 
pat 0.0192 
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Table 3.  ROC curve analysis of ELISA data relating to antigen-specific serum IgG(T) 681	
levels horses from the UK and US: comparing cyathostomin-positive versus cyathostomin-682	
negative horses. Horses were naturally infected or were subjected to experimental 683	
infection. UK population (n=32) comprised 26 cyathostomin-positive, 6 cyathostomin 684	
(true) negative equids.  The US population (n=51) comprised 48 cyathostomin-positive 685	
and 3 cyathostomin (true) negative equids. The area under the curve, 95% confidence 686	
intervals (CI) and P values for the data generated by ROC curve analysis for each rGALA 687	
protein are shown.  A cut-off percentage positivity value is indicated for each recombinant 688	
protein, based on the value calcualated as the highest sum of percentage sensitivity and 689	
specificity values obtained in the ROC analysis.  690	
 691	
Protein AUC*  
(95% CI) 
P value Cut-off Sensitivity %  
(95% CI) 
Specificity % (95% 
CI) 
ash 0.94 
(0.87-0.99) 
< 0.0001 > 9.755 82.43  
(71.83-90.30) 
100.00 
(66.37-100.00) 
cat 0.91  
(0.82-1.01) 
< 0.0001 > 5.945 95.95  
(88.61-99.16) 
77.78  
(39.9-97.19) 
gol 0.90  
(0.82-1.00) 
< 0.0001 > 9.245 91.89  
(83.18-96.97) 
77.78  
(39.99-97.19) 
lon 0.94 
(0.88-1.00) 
< 0.0001 > 16.69 75.68  
(64.31-84.90) 
100.00 
(66.37-100.00) 
pat 0.93 
(0.86-1.00) 
< 0.0001 > 7.400 86.49  
(76.55-93.32) 
88.89  
(51.75-99.72) 
 692	
 693	
 694	
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Table 4. ROC curve analysis of ELISA data relating to antigen-specific serum IgG(T) 698	
levels in horses from the UK and US at various thresholds of larvae in the mucosa (total 699	
mucosal burden, TMB) and of larvae in the mucosa plus lumen (total worm burden, 700	
TWB). Horses were naturally infected or subjected to experimental infection. The area 701	
under the curve (AUC), 95% confidence intervals (CI), P values, cutoff values and % 702	
sensitivity and specificity are shown.  703	
Protein AUC* (95% CI) P value Cut-off 
Sensitivity%  
(95% CI) 
Specificity%  
(95% CI) 
TMB 0 larvae; Negatives: 17, Positives: 66 
ash 0.72 (0.57-0.87) 0.006 >8.88 87.88 (77.51-94.62) 52.94 (27.81-77.02) 
cat 0.74 (0.58-0.89) 0.003 >6.72 92.42 (83.20-97.49) 52.94 (27.81-77.02) 
gol 0.72 (0.577-0.87) 0.004 >11.36 78.79 (66.98-87.89) 64.71 (38.33-85.79) 
lon 0.76 (0.616-0.89) 0.001 >16.69 77.27 (65.30-86.69) 70.59 (44.04-89.69) 
pat 0.73 (0.57-0.89) 0.004 >9.78 74.24 (61.99-84.22) 76.47 (50.10-93.19) 
TWB 0 larvae; Negatives: 10, Positives: 73 
ash 0.91 (0.83-0.99) <0.0001 >9.76 82.19 (71.47-90.16) 90.00 (55.50- 99.75) 
cat 0.92 (0.83-1.00) < 0.0001 >6.53 93.15 (84.74- 97.74) 80.00 (44.39- 97.48) 
gol 0.91 (0.82-0.99) < 0.0001 >10.11 90.41 (81.24- 96.06) 80.00 (44.39- 97.48) 
lon 0.93 (0.86-0.99) < 0.0001 >16.69 76.71 (65.35- 85.81) 100.00 (69.15-100.00) 
pat 0.92 (0.85-0.99) < 0.0001 >9.78 72.60 (60.91- 82.39) 100.00(69.15-100.00) 
TMB 5,000 larvae; Negatives: 30, Positives: 53 
ash 0.69 (0.57-0.81) 0.004 >10.24 83.02 (70.20-91.93) 50.0 (31.30-68.70) 
cat 0.77 (0.66-0.88) < 0.0001 >11.25 71.7 (57.65- 83.21) 76.67 (57.72-90.07) 
gol 0.70 (0.58-0.82) 0.002 >20.90 66.04 (51.73-78.48) 70 (50.60-85.27) 
lon 0.74 (0.63-0.86) 0.0003 >31.17 60.38 (46.0-73.55) 83.33 (65.28-94.36) 
pat 0.74 (0.63-0.86) 0.0002 >9.780 81.13 (68.03-90.56) 66.67 (47.19-82.71) 
TWB 5,000 larvae; Negatives:18, Positives: 65 
ash 0.75 (0.61-0.88) 0.0015 >8.880 89.23 (79.06-95.56) 55.56 (30.76-78.47) 
cat 0.82 (0.70-0.94) < 0.0001 >11.25 66.15 (53.35-77.43) 88.89 (65.29-98.62) 
gol 0.79 (0.67-0.91) 0.0002 >19.72 64.62 (51.77- 76.08) 83.33 (58.58-96.42) 
lon 0.82 (0.71-0.93) < 0.0001 >17.89 76.92 (64.81-86.47) 83.33 (58.58-96.42) 
pat 0.78 (0.66-0.90) 0.0003 >10.78 64.62 (51.77-76.08) 83.33 (58.58-96.42) 
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Figure 1.  ClustalW alignment of Cy-GALA-pat with its orthologues in other 707	
cyathostomin species.   708	
Cy-GALA-pat (Accession Number: FJ882059) is aligned with GALA proteins from four 709	
additional cyathostomin species, Cylicocyclus ashworthi (Accession number, JN596964), 710	
Cyathostomum catinatum (Accession number, JN596966), Cylicostephanus longibursatus 711	
(Accession number, JN596968) and Cylicostephanus goldi (Accession number, 712	
JN596967).  The signal peptide for each sequence is underlined and the domain of 713	
unknown function (DUF148) is boxed. The histidine-rich region is highlighted in grey. 714	
 715	
Figure 2. Specificity of the four recombinant GALA proteins.   716	
A. Coomassie stained SDS-PAGE gel depicting all four new recombinant GALA proteins. 717	
ash = C. ashworthi recombinant protein; cat = C. catinatum recombinant protein, gol = C. 718	
goldi recombinant protein,  lon = C. longibursatus recombinant protein, M = molecular 719	
weight marker. B.  Immunoblots of each recombinant protein (rCy-GALA-ash, rCy-720	
GALA-cat, rCY-GALA-gol and rCy-GALA-lon) probed for IgG(T) reactivity using sera 721	
from helminth free (HF) ponies, experimental cyathostomin-infected (CI) ponies and  722	
horses infected monospecifically with either Parascaris equorum (Pe), Strongylus 723	
edentatus (Se), Strongyloides westeri (Sw) or Strongylus vulgaris (Sv).  M = molecular 724	
weight marker.  725	
 726	
Figure 3. Immunogenicity of the recombinant GALA proteins.   727	
A. Immunoblot of each recombinant protein (rCy-GALA-ash, -cat,  -gol and -lon) probed 728	
for binding of IgG(T) in a pool of serum from UK naturally infected horses, each of which 729	
had a total cyathostomin encysted larval burden of > 100,000 larvae. B. Immunoblot of 730	
each recombinant protein (rCY-GALA-ash, -cat,  -gol and -lon) probed for binding of 731	
	 32	
IgG(T) in a pool of serum from larval clinical cyathostominosis cases from the UK.  C.  732	
Immunoblot of each recombinant protein (rCy-GALA-ash, -cat,  -gol and -lon) probed for 733	
binding of IgG in sera from a rabbit taken before (P) and after (I) immunisation with the 734	
cyathostomin encysted larval 20 kDa complex (Dowdall et al., 2003).  D. Immunoblot of 735	
each recombinant protein (rCy-GALA-ash, -cat,  -gol and -lon) probed for binding of IgG 736	
in sera from a rabbit taken before (P) and after (I) immunisation with rCy-GALA-pat 737	
(McWilliam et al., 2010).  738	
 739	
Figure 4. IgG(T) responses in experimentally infected ponies to the four recombinant 740	
GALA proteins as measured by the ELISA 741	
Recombinant GALA (A. rGALA-ash, B. rGALA-cat, C. rGALA-gol, D. rGALA-lon) 742	
protein-specific IgG(T) responses over an experimental trickle infection (Murphy and 743	
Love, 1997).  Six British native-breed ponies (6-12 months at the time of initial infection) 744	
were reared indoors with their dams and considered to be helminth-naive prior to the start 745	
of the trial. Following weaning at 4 months, the ponies were maintained on a high-fibre 746	
pelleted ration and bedded on wood shavings.  Three ponies (Ponies 101, 104 and 105) 747	
were infected with a total of 3.9 million cyathostomin third stage larvae (L3), administered 748	
as a trickle infection of 150,000 L3 by nasogastric tube, three times a week. Ponies 102, 749	
103 and 106 were maintained as uninfected controls.  Pony 104 was necropsied at 20 750	
weeks post-infection and the remaining ponies at 60-62 weeks post-infection.  751	
 752	
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 753	
 754	
 755	
Cy-GALA-pat       MNKTLTFLTVVSAVALAQGVMDLFGEEGREEHRRHHRHSLLPPYLHNVSCEAKWEYFKIV 60 
Cy-GALA-cat       --------------------------EDREEHRRHHRHSLLPPYLHNVSCVAKWEYFRIV 34 
Cy-GALA-gol       MNKTLTFLTVVSAVVLAQGVMALFGEESREEHRRHHRHSLLPPYLHNVSCVAKWEYFKIV 60 
Cy-GALA-lon       MNKTLTFLTVVYAVVLAQGVMDLFGEEGREEHRRHHRHSLLPPYLHNVSCVAKWEYFKIL 60 
Cy-GALA-ash       ----------------------------HEELRRHHRHSLLPPYLHNVSCEAKWEYFKIV 32 
                                                                  ** ******:*: 
 
Cy-GALA-pat       GNRSLTFAEKRKEISEWAKKYNVVDEVASYNAYREKLKQEHRKNVSELVSALPNAVKKVN 120 
Cy-GALA-cat       GNRSLTFAEKKKEISEWAKKYNVLDEVASYNAYREKLKQEHRKNVSELVSDLPKAVKKVN 94 
Cy-GALA-gol       GNRSLTFAEKKKEISEWAKKYNVVDEVASYNAYREKLKQEHRKNVSELVSDLPNAVKKVN 120 
Cy-GALA-lon       GNRSLTFAEKKEKISEWAKKYNVVDEVASYNACREKLKQEHRKNVSEIVSNLPNAVKKVN 120 
Cy-GALA-ash       GNRSLTFAEKKGKSSEWAKKYNVVDEVASYNAYREKLKQEHRKNVSELVSGLPGAVKKVN 92 
                   *******::: : *:*****:* ******** ******:*******:** ** **::** 
 
Cy-GALA-pat       DLLDNENQTPRQLYVALRKLGRQNPALYRIVEYINVAVRLRSEEVDEQEQRRRLSALPFG 180 
Cy-GALA-cat       DLLDNENQTPRQLYVALRELGRQNPTLYRIVEYINVAVRRRSEELDEQEQGRRLSALPFG 154 
Cy-GALA-gol       DLLDNENQTSRQLYVALRELGRQNPALYRVVEYINVAVRLRRKEQDEQERQGTLSALPFG 180 
Cy-GALA-lon       DLLDNENQTPRQLYVALRKLGKQNPALYRVVEYINVLVRLRREEFDE-DQRRSLSALPFG 179 
Cy-GALA-ash       ELLDNENQTPRQLYVALRKLGKQNPVLYRVVEFVNLVVRFRREDSDEQEQREMLSTLPFS 152 
                  .********.:***:***:**:***.**::**::*: ** : :: *: ::   **   *. 
 
Cy-GALA-pat       DHNDNLEEQDFGEQDFRYVYGFECARFLLQNGRMFGLNTDERY- 223 
Cy-GALA-cat       DNNDNLEEQDFGEQDFRYVYGFECARFLLQNGRMFGLNTDERD- 197 
Cy-GALA-gol       ENNDNLEEQDFGEQDFRYVYGFECARFLLQNGRMFGLNTDRRYQ 224 
Cy-GALA-lon       DNNDDLEEQDFGEQDFRYIYGFECARFILQNGRMFGINTDRRY- 222 
Cy-GALA-ash       ENN---EEQDLGEQDFQYIYGFECARFIFQNGRMFGLNTDRRY- 192 
                  ::*   ****:**:**:*:********::*******:* *..   
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